| Metric | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue from operations | 24.9 | 17.2 | 3.5 |
| Other income | 0.3 | 0.2 | 0.2 |
| Total income | 25.3 | 17.4 | 3.7 |
| Profit before exceptional items & tax | 3.3 | 2.3 | 0.0 |
| Profit before tax | 3.3 | 2.3 | 0.0 |
| Net profit | 2.6 | 1.7 | 0.0 |
| Operating margin | 13.0% | 13.2% | 0.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, quarter on quarter | +52.90% |
|---|---|
| Revenue, year on year | +611.40% |
| Operating profit, year on year | +1600.00% |
| Operating profit, quarter on quarter | +42.90% |
NSE results filing, NSE: ARVEE. Figures extracted from the filing.
Arvee Laboratories (India) Ltd: key numbers
- Share price
- ₹215.60
- Market cap
- ₹237.6 Cr
- Revenue (annual)
- ₹31.51 Cr
- Net profit (annual)
- ₹2.53 Cr
- P/E (TTM)
- 58.6×Sector 33.9×
- Promoter holding
- 73.50%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Arvee Laboratories (India) Ltd
All →Arvee Laboratories (India) Management Change
Arvee Laboratories appointed Shalin Chokshi as Executive Director and Duttsagar Chavda as Company Secretary, both effective 3 November 2026. Non-executive director Saurin Gandhi resigned from the Board effective the same date.
Arvee Laboratories (India) Board Meeting Date
Arvee Laboratories (India) Limited will hold a board meeting on November 3, 2026, to consider and approve its standalone unaudited financial results for the quarter ending September 2026.
Arvee Laboratories (India) Annual General Meeting
Arvee Laboratories (India) Limited held its 14th Annual General Meeting on September 29, 2026. The meeting covered adoption of financial statements and re-appointment of directors.
Arvee Laboratories (India) Management Change
Arvee Laboratories announced the resignation of Raina Singh as Company Secretary and Compliance Officer, effective September 9, 2026.
Arvee Laboratories (India) Q1 FY27 Results: Net Profit ₹1.7 Cr, Up 750.0% YoY
Arvee Laboratories (India) Ltd reported revenue from operations of ₹17.2 Cr (+129.3% YoY) and net profit of ₹1.7 Cr (+750.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹1.7 Cr · +750.0% YoY
Arvee Laboratories (India) Board Meeting Date
Arvee Laboratories (India) Limited has scheduled a board meeting for August 7, 2026. The agenda includes reviewing quarterly standalone unaudited financial results and a scheme of arrangement.